Company Profile
Cara Therapeutics Stock Price, News & Catalysts
- Ticker:
- CARA
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for CARA.
Company overview
Business overview
Cara Therapeutics is a specialty pharmaceutical company with a history in pain and pruritus and a current story shaped by pipeline and commercial reset. The company has had to redefine its growth path.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Cara sits in specialty biopharma.
Business Model Characteristics
The business depends on product execution, strategic repositioning, and the ability to build a more durable portfolio.
Position Within the Biotechnology Landscape
Cara is a turnaround-sensitive specialty-pharma name with limited tolerance for disappointment.
Future catalysts
- Cara’s catalysts are its remaining legacy pruritus assets and any strategic update after the KORSUVA divestiture. The company is mainly in a reset / repositioning phase now.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Cara Therapeutics do?
Cara Therapeutics is a specialty pharmaceutical company with a history in pain and pruritus and a current story shaped by pipeline and commercial reset. The company has had to redefine its growth path.
On which exchange is CARA stock listed?
Cara Therapeutics (CARA) is associated with NASDAQ, United States, Biopharma.
What is Cara?
Cara’s catalysts are its remaining legacy pruritus assets and any strategic update after the KORSUVA divestiture.
Which conditions is Cara Therapeutics targeting with Cara?
Cara’s catalysts are its remaining legacy pruritus assets and any strategic update after the KORSUVA divestiture.
How does Cara Therapeutics describe recent progress with Cara?
Cara’s catalysts are its remaining legacy pruritus assets and any strategic update after the KORSUVA divestiture.
What is Therapeutics?
Cara Therapeutics is a specialty pharmaceutical company with a history in pain and pruritus and a current story shaped by pipeline and commercial reset.
What should investors watch for with Therapeutics?
Cara’s catalysts are its remaining legacy pruritus assets and any strategic update after the KORSUVA divestiture. The company is mainly in a reset / repositioning phase now.
What future catalysts are investors watching for Cara Therapeutics?
Cara’s catalysts are its remaining legacy pruritus assets and any strategic update after the KORSUVA divestiture. The company is mainly in a reset / repositioning phase now.